Epstein Secrets

rred at=a 6.3% current yield to March 2018. Let me know if you hav= time for a call; I'm at l> .<=u> Thanks,<=> Amanda Amanda Ens</=> Director Bank of America Merril= Lynch Merrill Lynch, Pierce,=Fenner & Smith Incorporated One Bryant Park, 5th F=oor, New York, NY 10036 Phone: Mobil= </=> The power of global co=nec

to TEVA was already built into most analyst models, the =NDA sale was not. Revenue thus looks 3 EFTA_R1_01555604 EFTA02454073 in line. Botox and Restasis, two impo=tant products, are still growing at 16% and 21% respectively. AGN has an aggressive buyback program, target=ng $5bn this year and they sho

to March 2018. Let me know if you hav= time for a call; I'm at 212.449.7781 <tel:212.449.7781> .<=u> Thanks,<=> Amanda Amanda Ens</=> Director Bank of America Merril= Lynch Merrill Lynch, Pierce,=Fenner & Smith Incorporated One Bryant Park, 5th F=oor, New York, NY 10036 Phone: 212.449.7781 <tel:212.449.7781> Mobil=: 9

s to TEVA. While=the generics sale to TEVA was already built into most analyst models, the =NDA sale was not. Revenue thus looks in line. Botox and Restasis, two impo=tant products, are still growing at 16% and 21% respectively. AGN has an aggressive buyback program, target=ng $5bn this year and they sho

ferred at=a 6.3% current yield to March 2018. Let me know if you hav= time for a call; I'm at .<=u> Thanks,<=> Amanda Amanda Ens</=> Director Bank of America Merril= Lynch Merrill Lynch, Pierce,=Fenner & Smith Incorporated 8 EFTA_R1_01556376 EFTA02454567

s to TEVA. While=the generics sale to TEVA was already built into most analyst models, the =NDA sale was not. Revenue thus looks in line. Botox and Restasis, two impo=tant products, are still growing at 16% and 21% respectively. AGN has an aggressive buyback program, target=ng $5bn this year and they sho